HCA Healthcare Inc (NYSE:HCA) Shares Acquired by Cigna Investments Inc. New

Share on StockTwits

Cigna Investments Inc. New lifted its holdings in shares of HCA Healthcare Inc (NYSE:HCA) by 5.6% during the 1st quarter, HoldingsChannel.com reports. The fund owned 7,501 shares of the company’s stock after buying an additional 400 shares during the period. Cigna Investments Inc. New’s holdings in HCA Healthcare were worth $674,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of HCA. Norges Bank acquired a new position in shares of HCA Healthcare during the 4th quarter valued at $435,961,000. Marshall Wace North America L.P. increased its stake in HCA Healthcare by 61,998.1% during the 4th quarter. Marshall Wace North America L.P. now owns 1,649,326 shares of the company’s stock worth $243,786,000 after buying an additional 1,646,670 shares during the period. Goldman Sachs Group Inc. increased its stake in HCA Healthcare by 18.9% during the 4th quarter. Goldman Sachs Group Inc. now owns 3,299,699 shares of the company’s stock worth $487,729,000 after buying an additional 524,907 shares during the period. Sumitomo Mitsui Trust Holdings Inc. increased its stake in HCA Healthcare by 37.1% during the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,511,384 shares of the company’s stock worth $135,798,000 after buying an additional 409,176 shares during the period. Finally, Los Angeles Capital Management & Equity Research Inc. increased its stake in HCA Healthcare by 119.2% during the 4th quarter. Los Angeles Capital Management & Equity Research Inc. now owns 616,930 shares of the company’s stock worth $91,188,000 after buying an additional 335,431 shares during the period. Institutional investors and hedge funds own 68.72% of the company’s stock.

Shares of NYSE:HCA opened at $106.69 on Monday. HCA Healthcare Inc has a fifty-two week low of $58.38 and a fifty-two week high of $151.97. The firm has a 50-day simple moving average of $103.68 and a 200 day simple moving average of $127.14. The company has a market cap of $36.02 billion, a PE ratio of 12.14, a P/E/G ratio of 2.50 and a beta of 1.31.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, April 21st. The company reported $2.33 earnings per share for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.31). HCA Healthcare had a net margin of 5.90% and a negative return on equity of 304.76%. The business had revenue of $12.86 billion for the quarter, compared to the consensus estimate of $13.12 billion. During the same period in the prior year, the company earned $2.97 EPS. HCA Healthcare’s quarterly revenue was up 2.7% on a year-over-year basis. As a group, analysts expect that HCA Healthcare Inc will post 4.62 earnings per share for the current fiscal year.

In related news, insider Jon M. Foster sold 24,220 shares of the business’s stock in a transaction dated Wednesday, May 6th. The shares were sold at an average price of $100.19, for a total transaction of $2,426,601.80. Following the completion of the sale, the insider now owns 49,212 shares of the company’s stock, valued at approximately $4,930,550.28. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.80% of the stock is owned by corporate insiders.

Several equities research analysts recently issued reports on the stock. Stephens lifted their price target on shares of HCA Healthcare from $175.00 to $180.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 29th. Goldman Sachs Group reaffirmed a “buy” rating and set a $165.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. SunTrust Banks dropped their price target on shares of HCA Healthcare from $160.00 to $140.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. UBS Group dropped their price target on shares of HCA Healthcare from $183.00 to $138.00 and set a “buy” rating on the stock in a research note on Monday, April 27th. Finally, Citigroup dropped their target price on shares of HCA Healthcare from $168.00 to $131.00 and set a “buy” rating for the company in a research report on Wednesday, May 20th. One research analyst has rated the stock with a sell rating, one has given a hold rating and fifteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $149.00.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: The Discount Rate – What You Need to Know

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.